Stock BDPT BIOADAPTIVES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News BioAdaptives, Inc.

Equities

BDPT

US09072U1079

Market Closed - OTC Markets
Other stock markets
 03:55:06 2024-04-23 pm EDT 		5-day change 1st Jan Change
0.0004 USD -20.00% Intraday chart for BioAdaptives, Inc. -20.00% -20.00%
Apr. 10 BioAdaptives, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Feb. 22 Bioadaptives, Inc. Announces Naturacomplete?, an All-In-One Supplement to Optimize Its Ai-Based FYO Obesity Management System CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioAdaptives, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
BioAdaptives, Inc. Announces NaturaComplete™, an All-In-One Supplement to Optimize Its AI-Based FYO Obesity Management System
AQ
Bioadaptives, Inc. Announces Naturacomplete?, an All-In-One Supplement to Optimize Its Ai-Based FYO Obesity Management System
CI
BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management
AQ
BioAdaptives Announces Signing of a New Distributor’s Agreement for AI Body Composition Measuring App and New Weight Management System
AQ
BioAdaptives Announces Signing of a New Distributor?s Agreement for AI Body Composition Measuring App and New Weight Management System
CI
Livestock Impact, Inc., Subsidiary of BioAdaptives, Inc., Launches Innovative Food Lab for Development of Treats and Supplement Powder for Human, Equine, and Canine Products
AQ
BioAdaptives, Inc. to Form New Division, AI BodyShape Lab, to Promote Adult Fitness and Weight Management
AQ
BioAdaptives, Inc. Introduces PROTEINnMORETM Ahead of 2024 Launch of AI-based “Fit Your Outfit” app
AQ
BioAdaptives Inc. Announces the Development of PROTEINnMORETM
CI
BioAdaptives Announces Special Holiday Wellness Offers and Gift
AQ
BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula
AQ
BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula
CI
BioAdaptives, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
BioAdaptives Highlights Continued Success of Popular LUNG ARMOR™ System as US Enters Flu Season
AQ
BioAdaptives, Inc. Highlights Continued Success of Popular LUNG ARMOR System as US Enters Flu Season
CI
BioAdaptives Takes Aim at Safe Pain Management with All-Natural Supplement
AQ
BioAdaptives Targets Multi-Billion Dollar Sleep Market with SleepEZ™ Natural Supplement
AQ
BioAdaptives, Inc. Celebrates Nine Years of Commercial Success in Equine Nutrition
AQ
BioAdaptives, Inc. Announces Nationwide Launch of Lung Fortress Natural Supplement
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BDPT Stock
  4. News BioAdaptives, Inc.